One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Drug Discovery Informatics Market

創薬インフォマティクス市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2022年


[ 英語タイトル ] Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022


Product Code : MNMHC00109185
Survey : MarketsandMarkets
Publish On : July, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.”
The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in 2017 at a CAGR of 11.2%. Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent.

“The sequencing and target data analysis segment is expected to account for the largest share in 2017.”
On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.
“The software segment is expected to account for the largest share in 2017.”
On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.
“North America is expected to account for the largest share during the forecast period.”
By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

Break-up profile of primaries:
• By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21%
• By Designation-C-level-36%, D-level-40% and Others-24%
• By Region-North America-40%, Europe-22%, Asia Pacific-30%, and RoW-8%
The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Research Coverage:
The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.
Reasons to buy this report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global drug discovery informatics market. The report analyzes the market by function, solution, end user, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global drug discovery informatics market

• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for global discovery informatics products across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global drug discovery informatics market

• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global drug discovery informatics market

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 12
1.4 CURRENCY 13
1.5 LIMITATIONS 13
1.6 STAKEHOLDERS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
2.1.1 SECONDARY DATA 15
2.1.1.1 Secondary sources 15
2.1.2 PRIMARY DATA 15
2.1.2.1 Key data from primary sources 16
2.1.2.2 Key industry insights 17
2.2 MARKET SIZE ESTIMATION 18
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4 ASSUMPTIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 DRUG DISCOVERY INFORMATICS: MARKET OVERVIEW 25
4.2 ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION AND END USER 26
4.3 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 27
4.4 GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 Rising R&D expenditure 29
5.2.1.2 Increasing focus on drug discovery 29
5.2.1.3 Need to control drug discovery and development costs 30
5.2.2 RESTRAINT 30
5.2.2.1 High pricing and setup cost of informatics software 30
5.2.3 OPPORTUNITIES 30
5.2.3.1 Patent expiry 30
5.2.3.2 Growing biotechnology industry 31
5.2.4 CHALLENGE 31
5.2.4.1 Scarcity of skilled professionals 31
6 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION 32
6.1 INTRODUCTION 33
6.2 SEQUENCING & TARGET DATA ANALYSIS 34
6.3 DOCKING 36
6.4 MOLECULAR MODELLING 37
6.5 LIBRARIES & DATABASE PREPARATION 39
6.6 OTHER FUNCTIONS 40
7 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION 42
7.1 INTRODUCTION 43
7.2 SOFTWARE 43
7.3 SERVICES 45
8 DRUG DISCOVERY INFORMATICS MARKET, BY END USER 47
8.1 INTRODUCTION 48
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 50
8.4 OTHER END USERS 52
9 DRUG DISCOVERY INFORMATICS MARKET, BY REGION 54
9.1 INTRODUCTION 55
9.2 NORTH AMERICA 56
9.2.1 US 58
9.2.2 CANADA 60
9.3 EUROPE 62
9.3.1 GERMANY 63
9.3.2 REST OF EUROPE 65
9.4 ASIA PACIFIC (APAC) 67
9.5 REST OF THE WORLD 70
10 COMPETITIVE LANDSCAPE 72
10.1 OVERVIEW 72
10.2 RANKING OF PLAYERS, 2016 73
10.3 COMPETITIVE SCENARIO 74
10.3.1 COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, & ACQUISITIONS 74
10.3.2 EXPANSIONS 75
10.3.3 PRODUCT LAUNCHES & ENHANCEMENTS 75
11 COMPANY PROFILES 76
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 JUBILANT LIFE SCIENCES 76
11.2 IBM 79
11.3 INFOSYS 82
11.4 THERMO FISHER SCIENTIFIC 85
11.5 PERKINELMER 88
11.6 SCHRÖDINGER 91
11.7 DASSAULT SYSTÈMES 93
11.8 CHARLES RIVER LABORATORIES 95
11.9 SELVITA 97
11.10 CERTARA 99
11.11 GVK BIOSCIENCES 100
11.12 COLLABORATIVE DRUG DISCOVERY 101
11.13 OPENEYE SCIENTIFIC SOFTWARE 102
11.14 IO INFORMATICS 103
11.15 NOVO INFORMATICS 104

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 105
12.1 INSIGHTS OF INDUSTRY EXPERTS 105
12.2 DISCUSSION GUIDE 106
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 109
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 111
12.5 AVAILABLE CUSTOMIZATIONS 113
12.6 RELATED REPORTS 114
12.7 AUTHOR DETAILS 115

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+